Trials for the co-expression of the merozoite surface protein-1 and circumsporozoite protein genes of Plasmodium vivaxCHOONGHEE LEE; KYUNG WON CHUNG; KIM, Tong-Soo et al.Experimental parasitology. 2011, Vol 129, Num 3, pp 227-233, issn 0014-4894, 7 p.Article

Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivaxBELL, Brian A; WOOD, James F; BANSAL, Reeta et al.Vaccine. 2009, Vol 27, Num 9, pp 1448-1453, issn 0264-410X, 6 p.Article

SAMPLING OF ADULT MOSQUITO VECTORS WITH MOSQUITO MAGNET^™ PRO IN PANAJI, GOA, INDIAKORGAONKAR, Nandini S; KUMAR, Ashwani; YADAV, Rajpal S et al.Journal of the American Mosquito Control Association. 2008, Vol 24, Num 4, pp 604-607, issn 8756-971X, 4 p.Article

Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein : The role of GPI signal sequenceOPHORST, Olga J. A. E; RADOSEVIC, Katarina; HAVENGA, Menzo J. E et al.Vaccine. 2007, Vol 25, Num 8, pp 1426-1436, issn 0264-410X, 11 p.Article

Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosisBERGMANN-LEITNER, Elke S; LEITNER, Wolfgang W; DUNCAN, Elizabeth H et al.Vaccine. 2009, Vol 27, Num 41, pp 5700-5708, issn 0264-410X, 9 p.Article

A new polymerase chain reaction/restriction fragment length polymorphism protocol for Plasmodium vivax circumsporozoite protein genotype (VK210, VK247, and P. vivax-like) determinationTOME ALVES, Renata; MARINS PBVOA, Marinete; GOLDMAN, Ira F et al.Diagnostic microbiology and infectious disease. 2007, Vol 59, Num 4, pp 415-419, issn 0732-8893, 5 p.Article

High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New GuineaHENRY-HALLDIN, Cara N; SEPE, Daphne; SUSAPU, Melinda et al.Infection, genetics and evolution (Print). 2011, Vol 11, Num 2, pp 391-398, issn 1567-1348, 8 p.Article

Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoitesMISHRA, Satish; RAI, Urvashi; SHIRATSUCHI, Takayuki et al.Vaccine. 2011, Vol 29, Num 43, pp 7335-7342, issn 0264-410X, 8 p.Article

Wild isolates of Plasmodium falciparum from India show restricted polymorphism in T-helper cell epitopes of the circumsporozoite proteinBHATIA, Vinay; BHATTACHARYA, Pramatha R.Acta tropica. 2006, Vol 97, Num 3, pp 259-264, issn 0001-706X, 6 p.Article

Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite proteinMARTINS ALMEIDA, Ana Paula Morais; DIAS, Mariana Oliveira; FAGUNDES VIEIRA, Carolina de Almeida et al.Vaccine. 2014, Vol 32, Num 19, pp 2181-2187, issn 0264-410X, 7 p.Article

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primatesTEWARI, Kavita; FLYNN, Barbara J; NUSSENZWEIG, Michel C et al.Vaccine. 2010, Vol 28, Num 45, pp 7256-7266, issn 0264-410X, 11 p.Article

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteersLE, T. P; COONAN, K. M; PARKER, S. E et al.Vaccine. 2000, Vol 18, Num 18, pp 1893-1901, issn 0264-410XArticle

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS, S/AS02AEPSTEIN, Judith E; CHAROENVIT, Yupin; MAJAM, Victoria et al.Vaccine. 2004, Vol 22, Num 13-14, pp 1592-1603, issn 0264-410X, 12 p.Article

Evolutionary dynamics of the immunodominant repeats of the Plasmodium vivax malaria-vaccine candidate circumsporozoite protein (CSP)PATIL, Aarti; ORJUELA-SANCHEZ, Pamela; DA SILVA-NUNES, Mônica et al.Infection, genetics and evolution (Print). 2010, Vol 10, Num 2, pp 298-303, issn 1567-1348, 6 p.Article

Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02AWALSH, Douglas S; GETTAYACAMIN, Montip; HOLLAND, Carolyn A et al.Vaccine. 2006, Vol 24, Num 19, pp 4167-4178, issn 0264-410X, 12 p.Article

Malaria epidemiology in low-endemicity areas of the Atlantic Forest in the Vale do Ribeira, São Paulo, BrazilCURADO, Izilda; DOS SANTOS MALAFRONTE, Rosely; DUARTE, Ana Maria Ribeiro De Castro et al.Acta tropica. 2006, Vol 100, Num 1-2, pp 54-62, issn 0001-706X, 9 p.Article

Epidemiological situation of malaria in Madagascar: Baseline data for monitoring the impact of malaria control programmes using serological markersRAZAKANDRAINIBE, Romy; THONIER, Vincent; DOMARLE, Olivier et al.Acta tropica. 2009, Vol 111, Num 2, pp 160-167, issn 0001-706X, 8 p.Article

Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoidTARTZ, Susanne; RUSSMANN, Holger; KAMANOVA, Jana et al.Vaccine. 2008, Vol 26, Num 47, pp 5935-5943, issn 0264-410X, 9 p.Article

Immunogenicity of Ty-VLP bearing a CD8⁺ T cell epitope of the CS protein of P. yoelii : enhanced memory response by boosting with recombinant vaccinia virusOLIVEIRA-FERREIRA, J; MYAHIRA, Y; LAYTON, G. T et al.Vaccine. 2000, Vol 18, Num 17, pp 1863-1869, issn 0264-410XArticle

Plasmodium vivax circumsporozoite variants and Duffy blood group genotypes in the Brazilian Amazon regionSTORTI-MELO, Luciane M; DE SOUZA-NEIRAS, Wanessa C; ROSSIT, Andréa R. B et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009, Vol 103, Num 7, pp 672-678, issn 0035-9203, 7 p.Article

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adultsKESTER, Kent E; MCKINNEY, Denise A; KRZYCH, Urszula et al.Vaccine. 2007, Vol 25, Num 29, pp 5359-5366, issn 0264-410X, 8 p.Article

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of ResearchKESTER, Kent E; CUMMINGS, James F; DOWLER, Megan G et al.Vaccine. 2008, Vol 26, Num 18, pp 2191-2202, issn 0264-410X, 12 p.Article

Genetic diversity of T-helper cell epitopic regions of circumsporozoite protein of Plasmodium falciparum isolates from IndiaBHATTACHARYA, Pramatha R; BHATIA, Vinay; PILLAI, C. R et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2006, Vol 100, Num 5, pp 395-400, issn 0035-9203, 6 p.Article

EPIDEMIOLOGICAL AND ECOLOGICAL ASPECTS RELATED TO MALARIA IN THE AREA OF INFLUENCE OF THE LAKE AT PORTO PRIMAVERA DAM, IN WESTERN SÃO PAULO STATE, BRAZILGOMES, Almério De C; DE PAULA, Marcia B; DUARTE, Ana Maria R. De C et al.Revista do Instituto de Medicina Tropical de São Paulo. 2008, Vol 50, Num 5, pp 287-295, issn 0036-4665, 9 p.Article

Evaluation of the VecTest Malaria Antigen Panel assay for the detection of Plasmodium falciparum and P. vivax circumsporozoite protein in anopheline mosquitoes in ThailandSATTABONGKOT, Jetsumon; KIATTIBUT, Chukree; KUMPITAK, Chalermporn et al.Journal of medical entomology. 2004, Vol 41, Num 2, pp 209-214, issn 0022-2585, 6 p.Article